JAK2 and myeloproliferative neoplasm: Indeed, the mean allele burden of JAK2 V617F for ET (39.4% ± 15.9) was significantly lower than that for PV (58.3% ± 29.7) and MPN-U (89.00% ± 8.64) (Table 1).